Federal Agency for Healthcare Research Faces Sharp Budget Cuts
聯邦醫療保健研究機構面臨大幅預算削減
更新於: 2026年8月4日 上午12:45
The Agency for Healthcare Research and Quality (AHRQ) is currently facing a severe operational crisis.
美國醫療研究與品質局（AHRQ）目前正面臨嚴重的運作危機。
Despite Congress allocating $345 million to the agency for the 2026 fiscal year, the Department of Health and Human Services has effectively halted its operations.
儘管國會已為該局編列2026財政年度3.45億美元的預算，但衛生與公眾服務部（Department of Health and Human Services）已實質停止其運作。
This executive action has led to the mass termination of existing grants, the cancellation of research competitions, and the suspension of critical scientific review panels.
此項行政命令導致現有撥款遭大規模終止、研究競賽被取消，並暫停了關鍵的科學審查小組。
Critics argue this represents an unlawful impoundment of funds, while the administration maintains it is prioritizing its own research agenda.
批評者認為這構成了違法扣留資金，而行政機關則堅稱正在優先執行其自身的研究議程。
The impact is significant: the agency’s workforce has shrunk from 300 to fewer than 100 employees, leaving it unable to function.
其影響極為深遠：該局的員工數已從300人縮減至不足100人，致使其無法正常運作。
AHRQ plays a vital role in improving healthcare delivery and reducing costs, distinct from the biomedical focus of the NIH.
隨著數百項涵蓋病患安全至行為健康的研究計畫被迫擱置，科學界警告，這種悄然解體機構基礎設施的行為，極可能會抹滅數十年來在全國醫療安全標準上所取得的進展。
